Rallybio has been named to the ‘Fierce 15’ list of biotech companies by the industry online pubication FierceBiotech.

“We all feel that we’ve got several more medicines left in us,” say Rallybio’s founders, the Alexion veterans Martin Mackay, Stephen Uden, and Jeffrey Fryer.

The team recently raised $37 million in funding to focus on developing new drugs for rare diseases.